Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,960.00
Bid: 1,969.00
Ask: 1,971.00
Change: 35.00 (1.82%)
Spread: 2.00 (0.102%)
Open: 1,937.00
High: 1,977.00
Low: 1,931.00
Prev. Close: 1,925.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: London Closes Mixed As Oil Prices Resume Fall

Mon, 12th Jan 2015 17:11

LONDON (Alliance News) - UK shares gave up their earlier gains Monday as oil prices resumed their slide, while European stocks were boosted by a report setting out the mechanics of a widely anticipated quantitative easing programme by the European Central Bank.

In a day with little fresh economic data, London shares opened higher and maintained their gains for most of the trading session. However, the FTSE 100 and FTSE 250 indices incurred sharp losses after US indices quickly overturned a higher open, though the FTSE 100 managed to recover somewhat in late trade.

The FTSE 100 closed flat at 6,501.42, while the FTSE 250 closed down 0.4% at 15,943.69. The small-cap AIM All-Share managed a gain, however, closing 0.1% higher at 703.92.

Stocks in mainland Europe outperformed London, as talk of ECB quantitative easing drove equities. CNBC reported Monday that the ECB could be set to reveal a program of quantitative easing whereby the amount of sovereign debt to be purchased by the ECB would be determined by the level of contributions made by each national central bank within the eurozone.

The next ECB monetary policy decision announcement and press conference by President Mario Draghi is set for January 22.

The CAC 40 in Paris ended up 1.2%, and the DAX 30 in Frankfurt closed up 1.4%.

At the London close, Wall Street was trading broadly lower. The DJIA was down 0.4%, the S&P 500 and Nasdaq Composite were both down 0.6%. The fourth-quarter reporting season in the US will get underway Monday with the release of aluminium producer Alcoa's fourth-quarter earnings report after the close of US trading.

Oil prices continued their downward path, with Brent falling below USD48 a barrel for the first time since the end of March 2009. At its lowest level of the day, Brent touched USD47.16 a barrel. The US benchmark West Texas Intermediate dropped to its lowest level since late April 2009. WTI hit a low of USD45.88 a barrel.

Oil-related stocks were amongst the biggest fallers in the FTSE 100 and FTSE 250. BG Group, down 3.6%, and Royal Dutch Shell 'B', down 1.6%, were amongst the biggest blue-chip losers. Hunting, down 8.1%, Premier Oil, down 6.7%, John Wood Group and SOCO International, both down 4.9%, Ophir Energy, down 4.8%, and Petrofac and Cairn Energy, both down 4.3%, were amongst the worst mid-cap performers.

Gold miners Fresnillo, up 1.1%, and Randgold Resources, up 1.0%, benefited as gold prices rose towards the end of trade. Gold rose to a high of USD1,231.23 an ounce, the yellow metal's highest level since December 11.

Afren, down 22%, was by far the biggest faller in the FTSE 250, hitting its lowest level since the end of March 2009. The oil and gas explorer said it is considering its options for the Barda Rash field in the Kurdistan region of Iraq after the reserve estimate for the prospect was revised down substantially.

Afren said an updated competent person's report on the Barda Rash field is expected to show a material reduction to its previously-published estimates on reserves and resources. The explorer said it expects the total reserve estimate for the field to be revised down to 250 million barrels of oil from 1.24 billion barrels previously.

AO World, up 6.6%, closed as the best mid-cap performer. The online domestic appliances retailer said website revenue rose 38% in its fiscal third quarter which includes the key Christmas trading period, with sales spiking around Black Friday but remaining strong in the run-in to the festive season. It added that it remains confident that it will meet full-year expectations.

Hikma Pharmaceuticals, up 4.3%, was another big riser in the FTSE 250. The company said it will now prepare to launch its colchicine 0.6 milligram capsules, after Takeda Pharmaceuticals USA Inc failed in its bid to block the distribution of the capsules. The US District Court for Delaware had denied Takeda's motion for a preliminary injunction in relation to the distribution of Hikma's colchicine capsules, and Himka said Monday that Takeda was unsuccessful in appealing this decision.

In the economic calendar Tuesday, Chinese new loans and trade balances data for December will be issued at 0200 GMT. UK consumer and producer price readings for December will be at 0930 GMT. The Kantar Worldpanel will release its latest UK grocery market-share figures for the 12 weeks ending January 4 at 0930 GMT.

In the corporate calendar, supermarket Wm Morrisons Supermarkets will be issuing a trading statement, as will bakery chain Greggs and fund manager Rathbone Brothers. Department store Debenhams, pub owner Spirit Pub Co and self-storage company Big Yellow Group will provide  interim management statements. Building products distributer SIG is scheduled to release a 2014 trading statement, recruitment company Michael Page International will issue a fourth quarter trading statement, and ASOS will release a Christmas press statement.

By Neil Thakrar; neilthakrar@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
6 Mar 2023 09:48

LONDON BROKER RATINGS: DB cuts Reckitt; Jefferies likes Tesco

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
1 Mar 2023 09:52

LONDON BROKER RATINGS: Canaccord says sell Future; Investec likes RWS

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
27 Feb 2023 09:38

Berenberg raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,440.0p to 1,740.0p on Monday on the back of the group's recent trading update.

Read more
27 Feb 2023 09:26

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
24 Feb 2023 09:37

LONDON BROKER RATINGS: SocGen cuts Burberry; BofA cuts WH Smith

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
23 Feb 2023 09:54

Hikma Pharmaceuticals profit halves in 2022 on Generics impairment

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported a dip in annual revenue for 2022, as profit tumbled due to high inflation and adjustments regarding expectations for its Generics business.

Read more
23 Feb 2023 09:02

LONDON MARKET OPEN: Mixed open in London; Rolls-Royce up, Mondi down

(Alliance News) - Stock prices in London opened mixed on Thursday, with large-cap indices underperforming amid mixed corporate earnings.

Read more
23 Feb 2023 07:59

Competition in generics sees Hikma Pharmaceuticals's profits decline by a tenth

(Sharecast News) - Hikma Pharmaceuticals posted lower full-year profits as stiff competition in generics saw its top line growth flatten out.

Read more
23 Feb 2023 07:56

LONDON BRIEFING: WPP profit jumps in 2022; guides for further growth

(Alliance News) - Stocks in London were called to open slightly higher on Thursday, as investors were unfazed by a fairly uneventful set of policy meeting minutes from the US central bank.

Read more
22 Feb 2023 21:50

Hikma accuses Amarin of suppressing generic versions of heart pill

Hikma claims Amarin used exclusive agreements with suppliers to frustrate generic rivals

*

Read more
16 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Friday 17 February 
Allianz Technology Trust PLCFull Year Results
Kingspan Group PLCFull Year Results
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
Monday 20 February 
Bank of Cyprus Holdings PLCFull Year Results
Georgia Capital PLCFull Year Results
Goldplat PLCFull Year Results (TBC)
LungLife AI IncFull Year Results
Tristel PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 21 February 
Antofagasta PLCFull Year Results
BHP Group LtdHalf Year Results
Blancco Technology Group PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
HSBC Holdings PLCFull Year Results
InterContinental Hotels Group PLCFull Year Results
Safestore Holdings PLCTrading Statement
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Trifast PLCTrading Statement
Wednesday 22 February 
Avingtrans PLCHalf Year Results
City of London Investment Group PLCHalf Year Results
Conduit Holdings LtdFull Year Results
Liberty Global PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Primary Health Properties PLCFull Year Results
Renewables Infrastructure Group LtdFull Year Results
Rio Tinto PLCFull Year Results
Synectics PLCFull Year Results
TBC Bank Group PLCFull Year Results
Transense Technologies PLCHalf Year Results
Thursday 23 February 
Anglo American PLCFull Year Results
Arbuthnot Banking Group PLCTrading Statement
BAE Systems PLCFull Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Drax Group PLCFull Year Results
Driver Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Made Tech Group PLCHalf Year Results
Mondi PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
Versarien PLCFull Year Results
WPP PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
25 Jan 2023 09:33

LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
18 Jan 2023 15:07

Director dealings: Hikma Pharmaceuticals director snaps up shares

(Sharecast News) - Hikma Pharmaceuticals revealed on Wednesday that non-executive director Deneen Vojta had acquired 1,000 ordinary shares in the FTSE 250-listed drugmaker.

Read more
12 Jan 2023 17:55

Arecor transfers AT307 drug to Hikma for development, regains AT282

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review.

Read more
3 Jan 2023 17:31

FTSE 100 ends first trading day of 2023 on upbeat note

FTSE 100 up 1.4%, FTSE 250 adds 1.5%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.